Vaughn, B.P.; Yarur, A.J.; Graziano, E.; Campbell, J.P.; Bhattacharya, A.; Lee, J.Y.; Gheysens, K.; Papamichael, K.; Osterman, M.T.; Cheifetz, A.S.;
et al. Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease. J. Clin. Med. 2020, 9, 3142.
https://doi.org/10.3390/jcm9103142
AMA Style
Vaughn BP, Yarur AJ, Graziano E, Campbell JP, Bhattacharya A, Lee JY, Gheysens K, Papamichael K, Osterman MT, Cheifetz AS,
et al. Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease. Journal of Clinical Medicine. 2020; 9(10):3142.
https://doi.org/10.3390/jcm9103142
Chicago/Turabian Style
Vaughn, Byron P., Andres J. Yarur, Elliot Graziano, James P. Campbell, Abhik Bhattacharya, Jennifer Y. Lee, Katherine Gheysens, Konstantinos Papamichael, Mark T. Osterman, Adam S. Cheifetz,
and et al. 2020. "Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease" Journal of Clinical Medicine 9, no. 10: 3142.
https://doi.org/10.3390/jcm9103142
APA Style
Vaughn, B. P., Yarur, A. J., Graziano, E., Campbell, J. P., Bhattacharya, A., Lee, J. Y., Gheysens, K., Papamichael, K., Osterman, M. T., Cheifetz, A. S., & Cross, R. K.
(2020). Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease. Journal of Clinical Medicine, 9(10), 3142.
https://doi.org/10.3390/jcm9103142
